Filing summary
Entity and period: The supplied filing is Sigma Labs, Inc.’s unaudited Form 10-Q for the quarter and nine months ended September 30, 2011—not a filing identified as Nexttrip, Inc. Sigma Labs is an early-stage manufacturing and materials technology company; its reported revenue was primarily from engineering consulting, not technology sales.
Financial performance and position
| Metric | Q3 2011 | Q3 2010 | Nine months 2011 | Nine months 2010 |
|---|---|---|---|---|
| Revenue | $369,613 | $243,936 | $670,126 | $276,436 |
| Gross profit | $347,571 | $127,842 | $496,482 | $160,342 |
| Gross margin | 94.0% | 52.4% | 74.1% | 58.0% |
| Net loss | $(36,789) | $(66,807) | $(964,271) | $(305,089) |
| Operating cash flow | Not stated by quarter | $(290,038) | $(212,643) |
Q3 revenue rose about 52% year over year and the quarterly net loss narrowed. Nine-month revenue increased about 142%, but the nine-month loss widened substantially, mainly reflecting higher operating expenses and $400,000 of noncash employee stock compensation. The filing reports loss per share of $(0.00), rounded to two decimals.
At September 30, cash was $939,091, versus $226,268 at December 31, 2010; working capital was $931,065, versus $362,497. Total assets were $1,085,338 and total liabilities $92,986, consisting of accounts payable and salaries payable. No borrowings or credit facilities were reported. Nine-month investing cash outflow was $8,904; financing provided $1,011,765, principally net proceeds from a common-stock offering. Cash increased $712,823.
Changes, outlook and risks
- The company sold 55,875,000 shares at $0.02 per share in a private offering closed April 15, 2011, reporting net proceeds of $1,011,765. It also issued 20 million restricted shares to employees, recorded as $400,000 noncash compensation. Common shares outstanding were 394,667,400 at September 30 and November 7, compared with 313,067,400 at December 31, 2010.
- Management expected general and administrative, payroll and noncash compensation expenses to increase as operations and marketing expanded. It reported five active consulting contracts expected to generate up to $143,103 in revenue for the balance of 2011.
- No formal revenue or earnings guidance was provided. Management believed available funds and expected consulting receipts would cover operating expenses through year-end 2011, but said future liquidity depended on consulting revenue and additional securities sales until technology sales became significant. It had no committed additional capital.
- The company stated it had not yet achieved profitable operations and identified continued operations as dependent on expanding income opportunities. Its target technologies remained under development, with no technology sales at the time. Fixed-price consulting contracts carry cost-estimation and execution risk.
- Approximately $1.32 million of tax loss carryforwards were available, but a full valuation allowance was recorded; ownership changes could limit their use. The filing reported no legal proceedings, disclosed contingencies, or subsequent events requiring disclosure.
Investor verification priorities
- Confirm the issuer: the provided metadata names Nexttrip, Inc., while the filing identifies Sigma Labs, Inc. (formerly Framewaves, Inc.).
- Verify the offering proceeds, placement costs and warrants, and the reported share-count changes and equity-plan issuances.
- Assess the quality and repeatability of consulting revenue, contract performance costs, and progress toward commercial technology sales.
- Reconcile the material nine-month loss and cash use, and evaluate the company’s dependence on future consulting income or equity/debt financing.
- Review the going-concern disclosure and whether funding assumptions beyond the stated remainder of 2011 were supported.